# FDA Inspection 1024147 - Nanjing Xingyin Pharmaceutical Group Co. Ltd. - August 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/nanjing-xingyin-pharmaceutical-group-co-ltd/15028054-5189-47ab-9bc9-611822a3d19d
Source feed: FDA_Inspections

> FDA Inspection 1024147 for Nanjing Xingyin Pharmaceutical Group Co. Ltd. on August 31, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1024147
- Company Name: Nanjing Xingyin Pharmaceutical Group Co. Ltd.
- Inspection Date: 2017-08-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1228230 - 2024-01-19](https://www.keypedia.com/records/fda_inspections/nanjing-xingyin-pharmaceutical-group-co-ltd/7eae7539-f0f4-49d7-b29f-b39c1bc91cdf)
- [FDA Inspection 1074969 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/nanjing-xingyin-pharmaceutical-group-co-ltd/4a078150-27fb-4cc1-8a6e-a4447c35eee6)
- [FDA Inspection 1024147 - 2017-08-31](https://www.keypedia.com/records/fda_inspections/nanjing-xingyin-pharmaceutical-group-co-ltd/148f570c-97e5-4b5b-a21a-b8bf7a8d9a79)

Company: https://www.keypedia.com/companies/nanjing-xingyin-pharmaceutical-group-co-ltd/1cf424d2-af24-425a-980f-07da6a534866

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c